Company
United StatesJoslin Diabetes Center Committee on Human Studies, Boston, MA – FDA Inspections
Inspection records and compliance data for Joslin Diabetes Center Committee on Human Studies in Boston, Massachusetts. 3 FDA inspections on record, last inspected November 27, 2018.
Company Profile
This profile covers Joslin Diabetes Center Committee on Human Studies based in Boston, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 2, 2009. Last inspected November 27, 2018.
Most cited issue areas
- Children as subjects1 inspection
- Information given to subjects1 inspection
- Initial and continuing reviews1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 27, 2018 | NAI | Human Drugs, Medical Devices & Rad Health · Bioresearch Monitoring | 1082467 |
| June 27, 2014 | VAI | Human Drugs, Medical Devices & Rad Health · Bioresearch Monitoring | 885331 |
| October 2, 2009 | VAI | Human Drugs, Medical Devices & Rad Health · Bioresearch Monitoring | 621686 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Flexion Therapeutics, Inc.
Steward St. Elizabeth's Med Ctr Boston, Inc. IRB #1
Harvard Faculty of Medicine IRB
Harvard Pilgrim Health Care Institutional Review Board
McLean Hospital Institutional Review Board
Reliant Medical Group IRB
Hallmark Health System IRB
Freedman, Sheldon J, MD, FACS
Frederick Memorial Hospital IRB
Paragon Packaging, Inc.
Company Information
Name
Joslin Diabetes Center Committee on Human Studies
FEI Number
1283624
Address
20 Overland St, Boston, Massachusetts 02215, United States
Country
United States
ID: 26aee5f5-b87b-4e15-a04e-1d8f8bb1ded3